Skin or kidney grafts often fail because the antigenic difference between donor and recipient is so great that immunosuppressive therapy is ineffective or must be pushed beyond the lethal limit. The number of transplantation antigens on tissue is large, and the chance of obtaining complete compatibility between donor and recipient is correspondingly low. However, from animal experiments it is known that certain antigens are more effective at inducing immunity than others. Incomplete compatibility is of less account if the antigens not matched are weak. There is therefore much interest in the development of a test that will discriminate between major and minor grades of incompatibility. Several methods are being investigated concurrently. These include serological tests for leukocyte and tissue antigens (1) (2) (3) (4) , a comparison of the speed at which a third party will reject skin from the patient as compared to the reaction against potential donors (5, 6) , mixed cell agglutination using kidney cells in tissue culture (7) , and the alteration observed in lymphocytes when exposed to foreign cells (8, 9) . Another test that has been suggested recently is the normal lymphocyte transfer test (10) . Lymphocytes from the patient are injected intradermally into each of a number of donors. The greater the antigenic diversity between patient and donor, the greater, it is thought, will be the reactive intensity of the transferred lymphocytes to antigens in the skin at the transfer site. Brent and Medawar, who introduced this test, found a positive correlation between lymphocyte reactivity and skin graft rejection in guinea pigs (10) . They have extended their observations to hybrid animals and find that cells from one of * Submitted for publication May 1, 1964 ; accepted October 19, 1964 .
Supported by U. S. Public Health Service grants Al K6 18 399 and GM 10356. the parental strains will react when injected into the other parental strain or into the hybrid. Hybrid cells do not react against the parent (11) . This finding is compatible with the hypothesis that the inflammatory response is immunological in nature and that it is primarily produced by the injected lymphocytes reacting against the new host. Hybrid cells contain the antigens of the parent and thus do not react; parental cells lack some antigens present in the hybrid and so will react. The genetic and immunologic bases of the test appear to be well established in the guinea pig.
When cells from a normal subject are injected into a series of normal human volunteers, there are differences in the degrees of inflammation produced. Gray and Russell injected lymphocytes from a potential graft recipient, R, into a series of subjects, D1, D2, D3, etc. A strong and a weak reactor were chosen to give skin to R. Skin from the strong reactor was more rapidly rejected than skin from the weak reactor (12, 13) .
In their original paper (10) Brent and Medawar suggested that nonspecific factors might influence the reaction in man. Bridges, Nelson, and McGeown have already shown that cells from a uremic subject may be less reactive than cells from a normal subject (14) , yet these are the very subjects most in need of a test for compatibility. The immunological reactivity of humans is often altered by disease, and actual immunization is a common sequel to repeated pregnancies (15) or blood transfusions (16) .
Because of the theoretical importance of this reaction in which normal lymphocytes apparently behave as "immunocytes" within 24 hours of transfer, and because of its great clinical significance, we have performed a series of tests designed to explore further the immunological parameters of the test in man.
In these experiments advantage has been taken 219 Downloaded from http://www.jci.org on April 25, 2017. https://doi.org/10.1172/JCI105136 of the known cross-reactivity between unrelated subjects. Leukocytes from one donor will specifically sensitize against skin from the same donor and also against skin from many other donors (5) . Antibodies found after parturition or blood transfusion also show a wide and complex pattern of reactivity (15, 16) . Thus, if a recipient has been sensitized by the injection of cells from three or more randomly selected individuals, it may be confidently assumed that he will react strongly against virtually any randomly selected donor. Methods
Test subjects. Three classes of subjects have been used. 1) Normal students, with a previous history of uneventful blood donation, who had not received blood or a skin graft. 2) Patients with an incurable but not incapacitating lung disease. These patients were ambulatory; most of them had an early but inoperable carcinoma of the lung. All were well nourished and free from obvious infection or complications of the disease. 3) Patients who were admitted for acute surgical procedures such as appendectomy or lacerations.' In this group of Negro subjects induration was minimal, and erythema was impossible to read except in albino or relatively fairskinned individuals; therefore, further experiments have been confined to white males. In no case were cells from a patient administered to a normal subject, but cells from one student were given to many of the patients to attempt to provide a form of standard reference.
Preparation of lymphocytes. In the first experiments phagocytic cells were separated with black magnetic oxide of iron; subsequently nylon columns were used to remove the majority of polymorphonuclear cells. Heparin, 1,000 ,O per 100 ml blood, was used as anticoagulant; all glassware was siliconized with Siliclad.
Separation with iron. The heparinized blood was mixed with 2.5 ml of 3%o gelatin (Plasmagel 2) for each 10 ml blood. After sedimentation for 30 minutes at room temperature in a siliconized tube, the supernatant fluid containing leukocytes, platelets, and some erythrocytes was centrifuged at 83 X g for 10 minutes. The cell pellet from each 10 ml of blood was resuspended in about 0.2 ml platelet free plasma and allowed to resediment for 30 to 40 minutes. The leukocyte-rich supernatant liquid was diluted to 5 ml with platelet free plasma containing 0.1 ml 2% black magnetic oxide of iron and 2% gum arabic in Ringer's solution and placed in a 20-ml vaccine bottle. The bottle was placed on its side in a shaking water bath at 400 C for 30 minutes; the cell suspension was then transferred to a 12-mm siliconized tube and held against the poles of a permanent magnet.
1 These patients were involved in a few pilot studies with Dr. W. Weaver. 2 Laboratoire Roger Bellon, Neuilly, Seine, France.
Iron-containing cells were drawn to the side of the tube, and the remainder of the suspension was placed in a similar tube and again exposed to the magnet; the cell suspension remaining generally consisted of 95% or more lymphocytes. The lymphocyte suspensions were centrifuged at about 100 X g and resuspended in physiological saline to a concentration of 5 X 107 per ml. The method frequently worked well with cells from normal subjects and was notable in that all classes of phagocytic cells including polymorphonuclear neutrophils, monocytes, and eosinophils together with most of the platelets were removed, leaving a virtually pure lymphocyte suspension with an occasional basophil. However, yields were somewhat erratic, and lymphocytes were sometimes trapped in excessive numbers; the amount of iron needed had to be adjusted to suit the proportion of polymorphs, and disappointing results were obtained in some of the disease states.
In later experiments, separation with nylon fibers has been used. The method is essentially that of Greenwalt, Gajewski, and McKenna (17) .. One hundred ml of blood was drawn into a vacuum bottle containing 5,000 U of heparin free from preservative and then passed under slight positive pressure through a column of nylon. DuPont nylon, 3 denier, 1 inch, no. 200, was washed in Duponol, dried, weighed into 4.0-g amounts, teased by brushing between two nylon hair brushes, and packed into a column 15 X 1.5 cm. The column was washed in Ringer's solution, capped with a vaccine stopper, and a glass bell attached to the lower end. The assembly was autoclaved wet. The blood was run through a tygon tube into the column, under sufficient pressure to give a flow of about 5 ml per minute. The effluent from the column was collected into 100-ml graduated cylinders containing 10 ml Alsevers solution. The first 75 ml of filtrate generally contained 97 to 99% lymphocytes and most of the red cells. In some cases the column could be washed through with saline to give a total of 150 ml of filtrate with very little contamination with polymorphonuclear neutrophils. The lymphocyte suspension was poor in platelets but did contain eosinophils and monocytes.
Gelatin was added in the proportion of 30 ml to 100 ml filtrate, and the red cells were allowed to settle for 45 minutes. The supernatant fluid was centrifuged at about 100 X g for 10 minutes, and the pellet was resuspended in 1.0 ml of platelet free plasma and allowed to resediment for 15 minutes. This second sedimentation removed the vast bulk of the remaining red cells that formed rouleaux in this concentrated suspension. The leukocyte layer was again removed and resuspended in heparinized saline to a final concentration of 5 X 107 per ml or 2.5 X 107 per ml. Any cells not required for the test were used in a parallel series of tissue culture experiments.
Polymorphonuclear leukocytes. Although a high yield of polymorphonuclear leukocytes (PMN) could have been obtained with iron separation, we felt that these cells could not be considered representative. Various methods of separation from nylon fibers or glass beads were tried, but the most satisfactory preparations were obtained by simple sedimentation. Fifteen ml of whole blood was drawn in 1.5 ml of 5% EDTA in saline. Leukocyte separation was obtained by the gelatin sedimentation previously described. A 25% sterile sucrose solution was diluted 1: 5 with sterile normal saline. The crude leukocytes were removed from the gelatin and resuspended in 0.5 ml of this solution. The lymphocytes were allowed to settle for 20 minutes at room temperature; then the supernatant fluid was removed and added to 1 ml of normal saline. After 15 minutes sedimentation the cells on the bottom were predominantly PMN. This sedimentation could be repeated with a resulting increase of purity and decrease in yield. The average purity was 97% and yield was 10 X 108 with this method.
Experimental design. Lymphocyte suspensions were injected via a no. 27 or 30 needle into the anterior aspect of the forearm. Each recipient usually received two injections from each of a series of donors, one injection of 5 X 10' and one of 2.5 X 10i cells. Each donor served in turn as recipient for cells from other participants in the experiment.
Erythema or induration as a criterion of measurement. The measurement of either erythema or induration is subject to considerable error, and a more objective measurement such as release of radioactivity would be preferable. Erythema is simple to read in most subjects but is of little value in deeply pigmented skins and is greatly affected by even gentle rubbing. Induration is a more satisfactory measure when the edges are sharply defined. The margins were diffuse in this type of reaction, especially in some subjects. Both measurements were recorded and paralleled each other during the first 48 hours; neither had any obvious advantage. Occasionally induration was absent when there was mild erythema, especially after the injection of autologous cells. In old lesions erythema and induration were coextensive.
Erythema was measured after 8 hours; induration and erythema were recorded every 24 hours for up to 8 days. 3 Reactions, erythema or induration, were scored as the mean of two diameters at right angles.
Controls. Five classes of controls have been included besides differential counts to check on the purity of the suspension and trypan blue uptake to test the viability of the cells. All suspensions contained over 90% lymphocytes. Viability was often over 99% and always over 95%. 1) In the controls for cutaneous hypersensitivity to injury, needle prick and saline injection were negative.
2) In the controls for nonspecific irritants in the plasma, the final supernatant plasma, containing anticoagulants and gelatin but without cells, was nonreactive.
3) Cell suspensions were injected back into the autologous host as a control for nonspecific effects in the cells themselves. In most normal subjects and in acute surgical patients there was a positive reaction to lymphocyte suspensions at 8 hours, but the inflammation subsided rapidly. 3 The majority of readings was made by Dr. Amos.
With only three exceptions reactions at 48 hours were trivial or negative. Autologous reactions were, however, common in the lung disease patients. Eight of the 21 tested gave a positive reaction at 48 hours; the tendency was most obvious in those patients who were generally hyperreactive. 4) Since humans vary greatly in their response to a variety of cutaneous irritants, a polyvalent bacterial suspension was given intradermally to a number of normal subjects. All responded, but there was no close correlation between the response to the vaccine and the average response to a number of cell suspensions given at the same time.
5) In the first experiment involving patients there were wider variations in the range of responses to lymphocyte suspensions than had been observed in normal subjects. Cells from a standard donor were therefore given as an additional control in subsequent experiments.
Results
Reproducibility within an experiment. Nine subjects were each given two injections of 5 X 106 cells from the same donor. The resultant lesions were measured daily for up to 5 days. Differences among the pairs of injections were surprisingly small. The mean difference for 47 pairs of determinations at the same dose level was 1.9 mm, and the standard deviation of the differences was ± 1.5. The average diameter of all lesions in this series was 9.1 mm. The test can therefore have good reproducibility within an experiment. Some results abstracted from the experiment are represented in Figure 1 The reactions involving either the cells from normal subject E or involving E as recipient in experiment 2 were not remarkable. E appeared to be no less reactive than the other subjects who had presumably been sensitized. The reactions of the remaining subjects with each other were roughly comparable to those observed in the first experiment, and only one reaction, B cells into D, was markedly different, converting from a doubtful reaction (2 mm) to moderately positive (8 mm).
Ten weeks later, experiment 4 involving most of the participants from the three previous experiments, together with one additional normal subject, was carried out. Twenty-one of the combinations had been tested twice, and a larger scale comparison could be made (Figure 2 (Figure 3,  1) , immune cells into normal subjects (Figure 3,  3) , normal cells into immune subjects (Figure 3 , 2), and normal cells into normal subjects ( Figure  3, 4) .
The reacted to lymphocytes but not to PMN. The third subject was the autologous control and was negative to both.
In another experiment, seven normal subjects were divided into two groups; the four subjects in group A received two injections each of 5 x 106 lymphocytes and four injections of PMN at doses of 5, 2.5, 1.25, and 0.5 x 106 in 0.1 ml from Subject G. Group B received a similar course of injections from Subject H. In this experiment, strong reactions to lymphocytes were matched by strong reactions to PMN in both induration and erythema ( Figure 4 ) (X2 for 6 degrees of freedom was 0.65, p > 0.99). All subjects responded to 1.25 x 106 or more PMN, and all but one reacted at the 0.5 x 106 level. Autologous controls were negative. The PMN suspensions were not pure but contained less than 10% lymphocytes; at the lowest dose level, therefore, less than 5 x 105 lymphocytes were injected as contaminants.
After nine days, the four subjects from group A and two subjects from group B were challenged with platelets and with three times frozen and thawed lymphocytes from the original immunizing donor, together with similar cells from seven other subjects. One of the subjects from group A responded briskly to all platelets injected, most of the lesions being over 10 mm in diameter at 48 hours. Another subject responded with small lesions of from 3 to 5 mm with five of the platelet suspensions at 24 hours and with only a minimal reaction-(2 mm) to the original donor at 48 hours; the remaining two subjects remained essentially negative. In group B, both subjects responded to platelets. Again one subject responded to all eight injections, whereas the other reacted more feebly and to only six. There was nothing to distinguish the reaction to the specific immunizing donor from the reaction to platelets from the other six subjects. In this experiment reactions to frozen and thawed lymphocytes were atypically brisk, erythema reaching a maximum of over 40 mm. This unusual reaction was tentatively attributed to the release of permeability factors from the damaged lymphocytes (some reactions are illustrated in Figure 4) .
In a third experiment in which different varieties of cells were compared, four normal and two previously immunized subjects were injected with both a highly purified lymphocyte suspension and a suspension rich in PMN from the same donor. Two normal subjects received cells from normal donors, and the others received cells from the immune donors. Each of the two immune subjects received cells from one of the normal and from the other immune subject. The cells were administered over a range from 105 to 5 X 106 cells. Of the two normal subjects given normal cells, one responded to both lymphocytes and PMN; the other responded less strongly to lymphocytes and only at the highest dose level to PMN. The two normal subjects receiving cells from previously immunized donors both responded to very small doses of cells. One had a relatively weak reaction to lymphocytes and a very feeble reaction to PMN; the other reacted briskly with both.
One of the immune recipients presented an interesting pattern. The With progressive immunization, all of the repeatedly immunized recipients are now producing antibodies. Antibody activity has been detected through leukoagglutination (18) and through cytotoxicity tests (19) . The two types of antibody do not have the same pattern of reactivity, and at least some of the sera are believed to have more than one agglutinin. The cross-reactions are shown in Table II . The highest titer that has been reached is 1/128 in the cytotoxicity test. These antibodies are being studied further and will be the subject of a separate report.
Experiments on patients with lung disease. Twenty-three patients with lung disease were divided into five groups. The first experiment involved four subjects. Each participant was tested with cells from the other three and with autologous cells. This group of subjects yielded a rather unexpectedly weak series of reactions. As an external control on the reactivity of the lymphocytes used for future experiments, cells from a normal healthy subject were injected into each of the remaining 19 subjects.
Responses in the patients, with three exceptions, appeared to be depressed as compared to the average lesion in normal subjects ( Figure 5 ).
Whereas the average of 43 reactions of nonimmunized normal subjects to normal cells was approximately 12.4 mm, the average for patients, excluding the three hyperreactive recipients, for 61 determinations at 48 hours was only 6.9 mm. This low value appeared to be in part an attribute of the cells, since cells from the normal subject gave lesions that were somewhat more pronounced and averaged 8.3 mm. The low average response was also greatly influenced by the complete nonreactivity of seven patients against one or more cells. On 11 Although normal lymph node cells were nonreactive, transferred leukocytes from 2 ml of peripheral blood from normal animals commonly induced very weak reactions. In four of 30 animals tested with normal blood leukocytes, stronger inflammation was observed (20) . Differences between strong and weak reactions to cells from the same cell donor later formed the basis for the normal lymphocyte transfer test. By using a more highly purified lymphocyte suspension, Brent and Medawar could show that positive reactions were indeed quite frequent and could be correlated with the antigenic diversity among the animals (10) . Finally they have established the genetic basis for the reaction in the guinea pig ( 11 ) . Collateral evidence for the extreme reactivity of peripheral lymphocytes comes from the experiments of Gowans (21) in which small lymphocytes from the thoracic duct converted to large pyroninophilic cells within 24 hours of intravenous injection, and from experiments in progress in our laboratory in which peripheral blood lymphocytes have converted to histiocytic cells within 18 hours of exposure to allogenic PMN in tissue culture.
Whereas peripheral lymphocytes from normal hosts appear to be highly reactive, cells from solid lymphoid organs appear to be less so. In the immune animal this distinction appears to disappear, and the reactions of immune cells described by Brent and his colleagues (20) appeared to be similar whether lymphocytes, peritoneal exudate cells, or lymph node cells were employed.
Many differences between man and guinea pig become apparent when results obtained from experiments in the two species are compared. Crossreactivity appears to be more widespread in man following the injection of normal cells, and the general level of reactivity is higher. Brent and Medawar have reported a number of 0 reactions and plus-minus (i.e., less than 2 mm) reactions in the guinea pig (10) . They specificially comment that a few of the reactions with normal cells were over 7 mm in diameter (10) . In healthy human subjects negative reactions appear to be extremely rare; 5 mm is a common minimal reaction, lesions up to 32 mm have been seen, and the average reaction is over 10 mm in diameter. Host versus graft reactions do not appear to be bothersome in the guinea pig until after the third day, whereas in several of our experiments with PMN or platelets, host versus graft (h.v.g.), reactions were very common within 24 hours. Relatively few reactions appeared the second day, and, paradoxically, late reactions were more common in presensitized subjects.
Immunization of either the donor or the recipient greatly enhances the reaction in the guinea pig. Immunization does not greatly enhance the reaction in man, either in terms of the speed of the reaction, the (14) . In some dosage experiments we have found a very close parallel between the reaction produced by the injection of a series of dilutions of lymphocyte suspensions of over 98% purity and a corresponding series of a crude PMN suspension in which only 10 to 15%o of the cells were lymphocytes.
At present, extensive speculation upon the reaction in man is not justifiable, but it is possible to draw some conclusions that will form the basis for further studies.
1) Specific immunological reactions are involved. The reaction is directed against or mediated by the cells themselves. Autologous reactions to lymphocytes, PMN, or platelets generally are negative, and only three controls with autologous lymphocytes remained positive in healthy subjects at the end of 48 hours. Control tests with saline used to suspend the cells or with gelatin-contaminated plasma in which the cells were originally prepared were also negative.
2) Internal reproducibility is excellent if great care is taken with the intradermal injections. Subcutaneous inoculations or variations in the total volume destroy the reproducibility. Almost identical lesions are obtained with the same suspension in different sites of the forearm or immediately above the elbow.
3) Most of the subjects in the patient group reacted abnormally in two respects. Reactions to autologous cells were much more common in patients than in healthy subjects. The patients themselves had an impaired ability to react. Not only were the reactions to cells from other patients impaired, but the reactions to a test cell from a healthy donor were also moderately depressed. Some of the poor reactivity was also due to deficiencies of the cells. Complete failure to produce any inflammation was observed with cells from one subject, and isolated negative reactions were relatively common in these patients. Current experiments with Dr. B. Hattler have shown that the condition is not analogous to the situation in Hodgkin's disease, since the transferred cells can react to mumps and other commonly reactive antigens even in patients with advanced metastatic carcinoma. Lamb, Pilney, Kelly, and Good (22) have shown that nontoxic, noncachexic patients with carcinoma are not anergic to a variety of antigens. The depressed reactivity of the patients in our series to transferred lymphocytes and the contrasting higher reactivity of three of them warrant further investigation.
4) Host versus graft factors are prominent in the human. Reactions to PMN in allogenic hosts have been encountered when low numbers (108) of PMN of 99% purity were injected and in the absence of nonspecific reaction in autologous hosts. The possibility of a pre-existent natural immunity in man must be considered although humoral antibodies have not been detected. Reactions to platelets and frozen and thawed lymphocytes were also occasionally positive in normal subjects. Sometimes the onset of reaction was delayed, suggesting a lag before the buildup of immunity, but more often the reaction was positive at 24 hours and might increase up to 48 hours just as the reaction with lymphocytes commonly built up to a maximum at 48 hours. Immunization of the cell donor does not increase the reactivity of the injected cells, and immunization of the recipient tends to decrease the intensity and duration of the reaction.
Host factors are important in man. Normal recipients will react against polymorphonuclear neutrophils (PMN) or frozen and thawed lymphocytes. Reactions against these immunologically incompetent targets may be well developed within 24 hours of injection. Since cell free plasma and autologous cell controls were negative, reactions against PMN are considered to be an expression of a host versus graft response.
A depressed reactivity was observed in patients with carcinoma of the lung. PMN and platelets from normal subjects and some lymphocyte suspensions from patients have a more restricted range of reactivity than normal lymphocytes. This suggests antigenic deficiencies in these cells.
The lymphocyte transfer test, while apparently valid as a test for histocompatibility in the guinea pig, is complicated in man by poor reproducibility, by host reactions against the injected cells, and possibly by a state of natural immunity against some leukocyte antigens.
